This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Preliminary Report of Fourteen Cases

IRA N. ROSENSTEIN, M.D.; HAROLD S. GOLDSTEIN, M.D.

AMA Arch Surg. 1962;84(5):536-545.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

Wound healing, or tissue repair, is an integral part of the physiologic processes of all living matter. It is an expression of self-preservation of a part or the whole organism. Although the histologic alterations associated with injury and ensuing tissue repair may appear to be numerous, they represent variations on a limited number of histologic themes. These limited reparative mechanisms, varying somewhat with the organ or tissue, are dependent upon numerous locally and/or systemically active physiologic factors, among them the blood circulation, fluid and electrolyte dynamics, serum proteins (both qualitative and quantitative), oxygen supply, vitamin levels, infection,^1-4 and perhaps many factors still unknown.

The use of iproniazid in wound healing is empirical at present. In 1958, Bosworth⁵ reviewed his cumulative findings of the accelerated healing effects of orally or parenterally-administered iproniazid in tuberculous bony lesions and found that they compared favorably with wound healing in similar, nontuberculous . . . [Full Text PDF of this Article]

Author Affiliations
MIAMI

Clinical Instructor, Department of Medicine, University of Miami School of Medicine; Consultant to Chest Clinic, Veterans Administration Hospital, Coral Gables (Dr. Rosenstein); Second-Year Resident, Department of Surgery, V.A. Hospital, Coral Gables (Dr. Goldstein).

Footnotes
Received for publication June 26, 1961.

Iproniazid was generously supplied as Marsilid Phosphate by Hoffmann-La Roche, Inc., Nutley, N.J.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?